Drugs / Bivalent oral poliovirus vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03202719 Comparator | Nov 2017 → Oct 2019 | poliomyelitis | Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bivalent oral poliovirus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03202719 ↗ |
| Known as | bOPV | “Bivalent oral poliovirus vaccine (bOPV) at 6,10 and 14 weeks of age” NCT03202719 ↗ |
| Modality | Vaccine | “Oral poliovirus vaccines are live attenuated viral vaccines” NCT03202719 ↗ |
| Route | Oral | “Bivalent oral poliovirus vaccine (bOPV) at 6,10 and 14 weeks of age” NCT03202719 ↗ |